MPA MVP regimen result in lower toxicity,longer median survival and better quality of life than those of MVP regimen,though there was no significant difference on the objective response rate between the two groups.

• 甲孕酮联合 MVP方案组与单纯 MVP方案治疗组疗效差异无显著性 ,但前者中位生存期长 ,患者生活质量改善 ,毒副反应小